NIH Holds Secret Meetings to Award Research Grants
Published Date: 5/18/2026
Notice
Summary
The Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and decide on important research grant applications. These meetings keep sensitive info private, protecting personal and trade secrets. Scientists applying for grants and the research community should note these dates as they impact funding decisions.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
NIH closed virtual grant reviews
If you applied for NIH research grants, your applications will be reviewed and evaluated during closed virtual meetings on June 8, 2026 and June 22-23, 2026 (multiple study sections listed). These meetings decide funding outcomes for the listed study sections and may directly affect whether your grant receives NIH funding.
Privacy and trade-secret protections enforced
These meetings are closed under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, commercial property (including patentable material), and personal information of applicants. That means sensitive technical details and personal data in grant applications will be kept private during the June 2026 reviews.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-09947 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for exciting health science projects. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-10022 — Submission for OMB Review; 30-Day Comment Request; Early Career Reviewer Program Online Application and Vetting System (Center for Scientific Review)
The NIH wants your thoughts on their Early Career Reviewer Program’s new online application and review system. This affects early career scientists applying to review research, making the process smoother and digital. You’ve got 30 days to share your feedback—no cost changes, just a smarter way to apply!
2026-10021 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and evaluate grant applications related to health and cancer research. These meetings are private to protect sensitive information and personal privacy. Researchers applying for grants and NIH staff are the main players, with no direct cost changes announced but important deadlines to keep in mind.
2026-09323 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late May and June 2026 to review important grant applications. These meetings protect private info and trade secrets while deciding which research projects get funding. Scientists and research institutions waiting on grants should note these dates as they impact funding decisions.
2026-09324 — National Institute of Allergy and Infectious Diseases; Notice of Meetings
The National Institute of Allergy and Infectious Diseases is holding virtual meetings on June 22, 2026, to review grant applications and share important updates. These meetings affect researchers and organizations seeking funding, with some sessions open to the public online and others closed to protect privacy. No new funding amounts are announced, but the grant review could impact future research support.
2026-09292 — Government Owned Inventions Available for License: Enhanced Tumor Reactivity of T Cells Lacking SIT1, LAX1 or TRAT1
The government has a cool new discovery that makes certain immune cells, called T cells, better at fighting cancer and other diseases by turning off some ‘brakes’ inside them. This could lead to stronger, smarter treatments for cancer, infections, and autoimmune problems. Companies interested in licensing this tech should act soon to help bring these powerful therapies to patients and the market.
Previous / Next Documents
Previous: 2026-09851 — Final Flood Hazard Determinations
FEMA has finalized updates to flood risk maps for several communities, changing flood zones and water levels that affect flood insurance rules. Homeowners, renters, and local governments need to check these new maps by July 7, 2026, to stay protected and insured. These changes could impact insurance costs and building rules, so it’s smart to stay informed and prepared!
Next: 2026-09853 — Self-Regulatory Organizations; 24X National Exchange LLC; Notice of Filing and Immediate Effectiveness of Proposed Rule Change To Establish Fees for Industry Members Related to Certain Historical Costs of the National Market System Plan Governing the Consolidated Audit Trail
24X National Exchange is setting new fees for industry members to cover leftover historical costs from the National Market System Plan for the Consolidated Audit Trail. These fees, called Historical CAT Assessment 1A, will collect about $39 million that wasn’t charged before. The new charges start right away and help pay for past expenses that keep the market running smoothly.